SCHEMBL3433399

SCHEMBL3433399

O=C(c1cc(Cl)ccc1Cl)N1CCN(c2cccnn2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.72
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
SLC6A7 Q99884 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
HPGD P15428 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
SCD O00767 1/20 0.53
ABL1 P00519 1/20 0.52
BCR P11274 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.50
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5270927 0.85 SCD (0.58) HSD17B10SLC6A7L3MBTL1ALDH1A1KDM4E
SCHEMBL11713011 0.80 LMNA (0.84) HSD17B10LMNATP53ALOX15TSHR
SCHEMBL938327 0.80 SCD (0.66) HSD17B10KMT2AMEN1LMNATP53
SCHEMBL26669418 0.79 HSD17B10 (0.70) HSD17B10KMT2AMEN1LMNATP53
SCHEMBL3434504 0.77 GAA (0.56) HSD17B10KMT2AMEN1TSHRSLC6A7
SCHEMBL15378796 0.77 HSD17B10 (0.45) HSD17B10LMNATP53ALOX15SCD
SCHEMBL3429910 0.76 SLC6A7 (0.62) HSD17B10KMT2AMEN1LMNATSHR
SCHEMBL18126694 0.76 ADRB2 (0.62) HSD17B10KMT2AMEN1LMNATP53
SCHEMBL14825161 0.75 TSHR (0.77) HSD17B10KMT2AMEN1LMNATP53
SCHEMBL27702525 0.75 SLC6A7 (0.63) HSD17B10KMT2ALMNATSHRSLC6A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257291-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS Xenon Pharmaceuticals Inc. (CA) 2010-12-08 EP disclosed
WO-2009106991-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2009-09-03 WO disclosed
EP-1851205-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2007-11-07 EP disclosed
WO-2006086447-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2006-08-17 WO disclosed